VYSIS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 07 Mar 2025)
What this means for you
Registered since 13 Nov 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86684397
- Registration number
- 5607387
- Mark type
- Stylized text
- Filed
- 06 Jul 2015
- Published for opposition
- 28 Jun 2016
- Registered
- 13 Nov 2018
- Attorney of record
- Jordan Heinz
Goods and services
- Class 005 — Pharmaceuticals: Reagents for medical use; tissue pretreatment solutions, wash reagents, and buffers for medical use; binding reagents for medical use; hybridization buffers for medical use; hybridization reagents for medical use
Owner
- Abbott Molecular Inc., Des Plaines, IL, US
- Abbott Molecular Inc., Des Plaines, IL, US
- Abbott Molecular Inc., Des Plaines, IL, US
Prosecution history
- 07 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 Mar 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Nov 2024 — TEAS SECTION 8 & 15 RECEIVED
- 13 Nov 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 May 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 May 2021 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 27 May 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 May 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Nov 2018 — REGISTERED-PRINCIPAL REGISTER
- 06 Oct 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Oct 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Aug 2018 — USE AMENDMENT FILED
- 17 Sept 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL